原发性硬纤维瘤型纤维瘤病患者的手术与非手术策略比较:法国肉瘤组全国性前瞻性队列研究
该全国性前瞻性队列纳入771例确诊硬纤维瘤型纤维瘤病(DTF)患者,比较手术与等待观察策略的无事件生存(EFS)。总体2年EFS为56%,手术组53%与等待观察组58%无显著差异(p=0.415)。肿瘤部位是主要预后因素:不利部位患者中等待观察组2年EFS 52%显著优于初始手术组25%(p=0.001)。
要点
- 总体2年EFS为56%,手术组53%与等待观察组58%无显著差异(p=0.415)。
- 有利部位(腹壁、腹腔内、乳腺、消化脏器、下肢)2年EFS为66%,不利部位为41%。
- 不利部位患者中,等待观察组2年EFS 52%显著优于初始手术组25%(p=0.001)。
核心结论
- DTF的部位是无事件生存的主要预后因素;若这些发现得到独立分析确认,DTF的个体化管理必须考虑这一易于获得的参数。
研究设计与样本
- 法国肉瘤组开展的前瞻性研究,纳入771例确诊DTF病例,分析基于手术后复发、等待观察期间疾病进展或治疗策略改变的无事件生存,采用log-rank检验和Cox模型识别预后因素。
主要发现
- 总体2年EFS为56%,手术组53% vs 等待观察组58%(p=0.415),两组无显著差异。
- 单因素分析中两个预后因素显著影响结局:诊断性取样的性质(p=0.466)和原发部位(p=0.0001)。
- 切开活检后2年EFS仅为32%。
- 有利部位(腹壁、腹腔内、乳腺、消化脏器、下肢)2年EFS为66%,不利部位为41%。
- 有利部位患者中,手术组2年EFS 70% vs 等待观察组63%(p=0.413),两组相似;不利部位患者中,初始等待观察组2年EFS 52% vs 初始手术组25%(p=0.001),等待观察组显著提高。
关键数值与推荐
- 总体2年EFS为56%;手术组53% vs 等待观察组58%(p=0.415)。
- 有利部位2年EFS为66%,不利部位为41%。
- 有利部位中手术组2年EFS 70% vs 等待观察组63%(p=0.413)。
- 不利部位中初始等待观察组2年EFS 52% vs 初始手术组25%(p=0.001)。
- 切开活检后2年EFS为32%。
临床怎么用
- 原文结论指出若发现得到独立分析确认,DTF的个体化管理必须考虑肿瘤部位这一易于获得的参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The outcome of desmoid-type fibromatosis (DTF) is unpredictable. Currently, a wait-and-see approach tends to replace large en bloc resection as the first therapeutic approach. Nevertheless, there are no validated factors to guide the treatment choice. METHOD: We conducted a prospective study of 771 confirmed cases of DTF. We analysed event-free survival (EFS) based on the occurrence of relapse after surgery, progressive disease during the wait-and-see approach, or change in therapeutic strategy. Identification of prognostic factors was performed using classical methods (log-rank test and Cox model). RESULTS: Overall, the 2-year EFS was 56%; this value did not differ between patients undergoing an operation and those managed by the wait-and-see approach (53% versus 58%, p = 0.415). In univariate analysis, two prognostic factors significantly influenced the outcome: the nature of diagnostic sampling (p = 0.466) and primary location (p = 0.0001). The 2-year EFS was only 32% after open biopsy. The 2-year EFS was 66% for favourable locations (abdominal wall, intra-abdominal, breast, digestive viscera and lower limb) and 41% for unfavourable locations. Among patients with favourable locations, the 2-year EFS was similar in patients treated by both surgery (70%) and the wait-and-see approach (63%; p = 0.413). Among patients with unfavourable locations, the 2-year EFS was significantly enhanced in patients initially managed with the wait-and-see approach (52%) compared with those who underwent initial surgery (25%; p = 0.001). CONCLUSION: The location of DTF is a major prognostic factor for EFS. If these findings are confirmed by independent analysis, personalised management of DTF must consider this easily obtained parameter.
引用
- Penel N, Le Cesne A, Bonvalot S, et al. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. Eur J Cancer. 2017. PMID: 28735069. doi:10.1016/j.ejca.2017.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。